Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389015 | SCV001590219 | pathogenic | Developmental and epileptic encephalopathy, 12 | 2020-05-04 | criteria provided, single submitter | clinical testing | Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PNKP are known to be pathogenic (PMID: 20118933, 25728773). For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with PNKP-related conditions (PMID: 29243230). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 29243230). This sequence change affects an acceptor splice site in intron 14 of the PNKP gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). |